Artificial intelligence in healthcare

AI radiology software to improve patient care

The Ultimate Guide to AI in Prostate Cancer

How does artificial intelligence work? What are promising AI applications in the prostate cancer pathway? Which solutions are available now?

AI in prostate cancer - homepage image-1


Quantib® Prostate receives FDA clearance 

We are proud to announce our 6th FDA clearance for our AI radiology solution Quantib® Prostate.

201021 - FDA clearance Quantib Prostate-2


    We push advanced technology forward to make sure radiologists can spend their time in the best way possible. Our engineers go to great lengths to create user-friendly radiology software solutions for challenging image analyses issues.


How can AI support radiologists even before they sit down to read a prostate MRI study?

by Arthur Post Uiterweer - CEO Quantib

There is a wide range of opportunities to improve the image-based diagnostic workflow even before the images are ready for reporting and reconstruction takes place. Specifically in the context of prostate MRI, what are the various value-adds that AI can offer? 


Curious for more detailed info on Quantib® Prostate or Quantib® ND Plus?

We are happy to schedule a call and give you the full tour of the solutions during a video conference.


Blog post

201021 - MRI prostate website card image

6 ways AI can support prostate MRI reporting

How can artificial intelligence can assist radiologists while reading prostate MRIs and help them become better and faster at this task with an increasing workload?

Read blog post


QND 1.6 Sample report resources (1)

Quantib® ND Sample Report

After analysis Quantib® ND Plus allows you to download an insightful report with a brief overview of quantified results, optional self-selected cross-sections and personal comments.

Download Report


A trick to get the best performance from an AI radiology algorithm: stratification

Dec 17, 2020 4:15:00 AM BY Jim Tol

Quantitative Radiology is Finally Coming

Nov 26, 2020 3:31:29 PM BY Tim Leiner

Subscribe for Updates